[go: up one dir, main page]

WO2005097186A3 - Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation - Google Patents

Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation Download PDF

Info

Publication number
WO2005097186A3
WO2005097186A3 PCT/US2005/011231 US2005011231W WO2005097186A3 WO 2005097186 A3 WO2005097186 A3 WO 2005097186A3 US 2005011231 W US2005011231 W US 2005011231W WO 2005097186 A3 WO2005097186 A3 WO 2005097186A3
Authority
WO
WIPO (PCT)
Prior art keywords
diabetics
type
vascular
bioligand
pecs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/011231
Other languages
English (en)
Other versions
WO2005097186A2 (fr
Inventor
Kenneth W Carpenter
William G Turnell
Kristen M Defife
Kathryn A Grako
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivas LLC
Original Assignee
Medivas LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivas LLC filed Critical Medivas LLC
Priority to EP05767563A priority Critical patent/EP1737379A4/fr
Priority to CN200580015085XA priority patent/CN1984620B/zh
Priority to JP2007507391A priority patent/JP2007532185A/ja
Priority to CA002562018A priority patent/CA2562018A1/fr
Priority to AU2005231458A priority patent/AU2005231458A1/en
Publication of WO2005097186A2 publication Critical patent/WO2005097186A2/fr
Publication of WO2005097186A3 publication Critical patent/WO2005097186A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne une endoprothèse vasculaire ou un autre dispositif médical implantable susceptible d'être enveloppée d'un polymère biocompatible biodégradable auquel on fixe un ligand biologique qui capture spécifiquement des progéniteurs de cellules endothéliales (PEC) dans le sang en circulation afin de favoriser la formation endogène d'un endothélium sain dans le diabète type II. Dans un mode de réalisation, le ligand biologique est un peptide qui se lie spécifiquement à un récepteur des intégrines sur les PEC. L'invention concerne également des procédés permettant d'utiliser des endoprothèses vasculaires et d'autres dispositifs médicaux implantables pour favoriser la guérison vasculaire dans le diabète type II, par exemple à la suite d'une intervention mécanique.
PCT/US2005/011231 2004-04-05 2005-04-04 Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation Ceased WO2005097186A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP05767563A EP1737379A4 (fr) 2004-04-05 2005-04-04 Endoprotheses vasculaires bioactives concues pour le diabete type ii et leurs procedes d'utilisation
CN200580015085XA CN1984620B (zh) 2004-04-05 2005-04-04 用于ⅱ型糖尿病患者的生物活性支架
JP2007507391A JP2007532185A (ja) 2004-04-05 2005-04-04 Ｉｉ型糖尿病のための生理活性ステントおよびその使用方法
CA002562018A CA2562018A1 (fr) 2004-04-05 2005-04-04 Endoprotheses vasculaires bioactives concues pour le diabete type ii et leurs procedes d'utilisation
AU2005231458A AU2005231458A1 (en) 2004-04-05 2005-04-04 Bioactive stents for type II diabetics and methods for use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55993704P 2004-04-05 2004-04-05
US60/559,937 2004-04-05

Publications (2)

Publication Number Publication Date
WO2005097186A2 WO2005097186A2 (fr) 2005-10-20
WO2005097186A3 true WO2005097186A3 (fr) 2006-09-14

Family

ID=35125623

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/011231 Ceased WO2005097186A2 (fr) 2004-04-05 2005-04-04 Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation

Country Status (6)

Country Link
EP (1) EP1737379A4 (fr)
JP (1) JP2007532185A (fr)
CN (1) CN1984620B (fr)
AU (1) AU2005231458A1 (fr)
CA (1) CA2562018A1 (fr)
WO (1) WO2005097186A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US9102830B2 (en) 2005-09-22 2015-08-11 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
US9517203B2 (en) 2000-08-30 2016-12-13 Mediv As, Llc Polymer particle delivery compositions and methods of use

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160287708A9 (en) * 2000-03-15 2016-10-06 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US20060271168A1 (en) * 2002-10-30 2006-11-30 Klaus Kleine Degradable medical device
US20070160622A1 (en) * 2005-12-07 2007-07-12 Medivas, Llc Method for assembling a polymer-biologic delivery composition
JP2007517550A (ja) 2004-01-02 2007-07-05 アドヴァンスド カーディオヴァスキュラー システムズ， インコーポレイテッド 高比重リポ蛋白をコーティングした医療デバイス
US8163269B2 (en) * 2004-04-05 2012-04-24 Carpenter Kenneth W Bioactive stents for type II diabetics and methods for use thereof
JP5196498B2 (ja) * 2006-05-09 2013-05-15 メディバス エルエルシー 生分解性水溶性ポリマー
US7572625B2 (en) * 2006-05-18 2009-08-11 Boston Scientific Scimed, Inc. Medical devices coated with drug carrier macromolecules
WO2008086490A2 (fr) * 2007-01-11 2008-07-17 Robert Lamar Bjork, Jr Endoprothèse coronaire à élution de médicaments multiples pour intervention coronarienne percutanée
JP2010533548A (ja) * 2007-07-17 2010-10-28 メディバス エルエルシー 生体吸収性エラストマー動脈支持装置および使用方法
US20090074831A1 (en) * 2007-09-18 2009-03-19 Robert Falotico LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS
DE102008027095A1 (de) * 2008-06-06 2009-12-17 Siemens Aktiengesellschaft Interventionsvorrichtung zur Sammlung von biologischem Material und Verfahren zu ihrer Herstellung
CN101879102B (zh) * 2009-05-07 2014-07-09 上海微创医疗器械（集团）有限公司 一种凹槽携载式涂层可降解型药物洗脱支架
CA2774036C (fr) * 2009-10-16 2018-04-03 Dsm Ip Assets B.V. Revetements comprenant du polyesteramide contenant des motifs bis(alpha-aminodiesters de diols)
ES2558357T3 (es) 2011-06-23 2016-02-03 Dsm Ip Assets B.V. Micro- o nanopartículas que comprenden un copolímero de poliesteramida biodegradable para uso en el suministro de agentes bioactivos
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
AU2012311451B2 (en) 2011-09-23 2017-08-10 Universitat Stuttgart Serum half-life extension using immunoglobulin binding domains
US9220759B2 (en) 2012-02-23 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
US9220584B2 (en) 2012-03-30 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a stent and locally administered adjunctive therapy
JP6351617B2 (ja) * 2012-12-20 2018-07-04 ディーエスエム アイピー アセッツ ビー．ブイ． 薬物送達のためのポリエステルアミドコポリマーを含むコーティング
CA2969171C (fr) 2014-12-18 2023-12-12 Dsm Ip Assets B.V. Systeme d'administration de medicament pour administration de medicaments sensibles aux acides
US20230009211A1 (en) * 2019-12-04 2023-01-12 Cortronik GmbH Swellable polymer hybrid fibres for a sleeve of an intraluminal endoprosthesis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020106369A1 (en) * 2000-03-17 2002-08-08 Millennium Pharmaceuticals, Inc. Method of inhibiting stenosis and restenosis
US20030064053A1 (en) * 2001-08-31 2003-04-03 Shengjiang Liu Multivalent protein conjugate with multiple ligand-binding domains of receptors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2229499T3 (es) * 1997-05-22 2005-04-16 Biomet Deutschland Gmbh Implantes recubiertos con peptidos y procedimiento para su fabricacion.
US7052711B2 (en) * 1999-09-02 2006-05-30 Rice University Nitric oxide-producing hydrogel materials
US6379383B1 (en) * 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
JP2001276210A (ja) * 2000-03-28 2001-10-09 Unitika Ltd 抗菌性医療用具及びその製造方法
GB0103668D0 (en) * 2001-02-15 2001-03-28 Biointeractions Ltd Methods and clinical devices for the inhibition or prevention of mammalian cell growth
AU2002233342B2 (en) * 2001-02-16 2007-10-25 Abbott Laboratories Vascular Enterprises Limited Implants with FK506 for prophylaxis and treatment of restonoses
CN1303947C (zh) * 2001-12-13 2007-03-14 华东理工大学 药物洗脱性心血管支架及其制备方法
WO2003065881A2 (fr) * 2002-02-06 2003-08-14 Orbus Medical Technologies Inc. Dispositif medical recouvert d'un revetement qui facilite la fixation et la differenciation de cellules endotheliales
JP2003320036A (ja) * 2002-05-01 2003-11-11 Terumo Corp ステント
JP2006520217A (ja) * 2003-02-26 2006-09-07 メディバス エルエルシー 生物活性ステントおよびその使用方法
WO2004100827A2 (fr) * 2003-05-07 2004-11-25 Advanced Bio Prosthetic Surfaces, Ltd. Greffons metalliques implantables et leur procede de fabrication
ATE361370T1 (de) * 2003-07-17 2007-05-15 Bayerische Julius Maximilians Verwendung von fak verwandten nicht kinase zur herstellung eines medikaments zur inhibierung der stenose und restnose

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020106369A1 (en) * 2000-03-17 2002-08-08 Millennium Pharmaceuticals, Inc. Method of inhibiting stenosis and restenosis
US20030064053A1 (en) * 2001-08-31 2003-04-03 Shengjiang Liu Multivalent protein conjugate with multiple ligand-binding domains of receptors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1737379A4 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9517203B2 (en) 2000-08-30 2016-12-13 Mediv As, Llc Polymer particle delivery compositions and methods of use
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US9102830B2 (en) 2005-09-22 2015-08-11 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use

Also Published As

Publication number Publication date
WO2005097186A2 (fr) 2005-10-20
AU2005231458A1 (en) 2005-10-20
CN1984620B (zh) 2011-03-30
JP2007532185A (ja) 2007-11-15
EP1737379A2 (fr) 2007-01-03
CA2562018A1 (fr) 2005-10-20
CN1984620A (zh) 2007-06-20
EP1737379A4 (fr) 2011-08-17

Similar Documents

Publication Publication Date Title
WO2005097186A3 (fr) Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation
Wnek et al. Encyclopedia of biomaterials and biomedical engineering
WO2005034852A3 (fr) Biomateriaux et biocoacervats proteiniques, leurs procedes de fabrication et d'utilisation
WO2007070790A3 (fr) Stents a auto-detection, stents a base de materiaux intelligents, systemes d'administration de medicaments, autres dispositifs medicaux et utilisations medicales de materiaux piezoelectriques materials
WO2006108065A3 (fr) Dispositifs medicaux implantables degradables
RU2400256C2 (ru) Захват эндотелиальных клеток-предшественников элюирующим лекарственные средства имплантируемым медицинским устройством
WO2007092464A3 (fr) Procedes et dispositifs pour la reparation de la coiffe des rotateurs
WO2001003607A3 (fr) Ensemble dispositif de fermeture bio-active d'anevrisme et kit
WO2010057177A3 (fr) Systèmes de greffe de vaisseaux à biocoacervats et biomatériaux protéiques et procédés pour leur fabrication et leur utilisation
WO2006121887A3 (fr) Materiaux implantables et methodes servant a empecher la formation d'adherences tissulaires
WO2005000284A3 (fr) Urees de diaryle pour de maladies mediees par le recepteur du facteur de croissance derive des plaquettes
WO2008098252A3 (fr) Implants vasculaires et procédés de fabrication desdits implants
WO2006138047A3 (fr) Systemes de pose et de guidage de stents
CA2467797A1 (fr) Biocompatibilite amelioree de dispositifs medicaux implantables
AU2002231175A1 (en) Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart
WO2006029364A3 (fr) Dispositif d'administration in vivo d'agents bioactifs et son procede de fabrication
ATE529074T1 (de) Gegabelte medizinprodukt-abgabevorrichtung
WO2005086831A3 (fr) Capture de cellules endotheliales progenitrices au moyen d'un dispositif medical implantable a elution medicamenteuse
KR20080108693A (ko) 코끝 성형술을 용이하게 하는 비연골기둥보조장치
WO2002053015A3 (fr) Composition de tissu vasculaire
WO2007030512A3 (fr) Greffon de diffusion de medicaments
WO2011071766A3 (fr) Greffes bioactives et composites
Fu et al. Combination of calcium sulfate and simvastatin-controlled release microspheres enhances bone repair in critical-sized rat calvarial bone defects
JPWO2011096402A1 (ja) 生体適合性器具
Wang et al. Covalent co-immobilization of heparin/laminin complex that with different concentration ratio on titanium surface for selectively direction of platelets and vascular cells behavior

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005231458

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2562018

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007507391

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 6024/DELNP/2006

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2005231458

Country of ref document: AU

Date of ref document: 20050404

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005231458

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2005767563

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200580015085.X

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2005767563

Country of ref document: EP